cristian-fitz documents

Orlistat 60 mg NDA 21-887 Label Comprehension Study Joint Nonprescription Drugs Advisory Committee and Endocrine and Metabolic Drugs Advisory Committee
Documents Orlistat 60 mg NDA 21-887 Label Comprehension Study Joint Nonprescription Drugs Advisory Committee and Endocrine and Metabolic Drugs Advisory Committee